Scala Biodesign
PrivateLast Round
Series A
Mar 31, 2026
Total Funding Raised
$21.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scala Biodesign is a biotechnology company that provides a computational platform using physics-based modeling, AI, and biological data analysis to engineer and design proteins for the pharmaceutical, chemical, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scala Biodesign Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Scala Biodesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2026 | ||||
| Seed | Sep 11, 2023 |
Key People
Founding team and executive leadership
Scala Biodesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deep Insight | Series A |
| Israel Innovation Authority | Series A |
| Grove Ventures | Series A |
| TLV Partners | Series A, Seed |
| Intel Ignite | Seed |
| Ignite DeepTech Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2026
Core technology developed at Weizmann Institute of Science.
- Mar 31, 2026
Developing ScalaOS, a platform for creating protein-based products.
Scala Biodesign Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scala Biodesign's valuation, stock price, and market status.